Evotec Technologies and Genedata Enter into Co-marketing Agreement to Offer Turn Key Solutions for Lead Discovery

16-Sep-2005

Evotec Technologies GmbH and Genedata AG announced that they entered into an agreement to combine their strengths in the area of High Content and High Throughput Screening.

Evotec Technologies and Genedata expect synergistic effects in combining Evotec Technologies' instrumentation (EVOscreen® and plate::explorer(TM)) and analysis software (Acapella(TM)) with Genedata's software system Genedata Screener®. The combination of both company's products provides more detailed information about potential lead structures, facilitating decision making within the drug discovery process and reducing the risk of costly late stage failures. Evotec Technologies and Genedata therefore decided to jointly promote the combined product offering as a one-stop solution.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances